Behavioural activation in nursing homes to treat depression (BAN-Dep): study protocol for a pragmatic randomised controlled trial.
Aged
Australia
Cognitive Behavioral Therapy
/ methods
Depression
/ therapy
Health Personnel
/ education
Homes for the Aged
/ organization & administration
Humans
Multicenter Studies as Topic
Nursing Homes
/ organization & administration
Outcome Assessment, Health Care
Pragmatic Clinical Trials as Topic
Quality of Life
Surveys and Questionnaires
aged care
behavioural activation
depression and mood disorders
elderly
randomised controlled trial
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
31 10 2019
31 10 2019
Historique:
entrez:
3
11
2019
pubmed:
5
11
2019
medline:
21
10
2020
Statut:
epublish
Résumé
Depression is a common disorder among older people living in residential aged care facilities. Several trials have demonstrated the effectiveness of behavioural therapies in treating depressive symptoms in older adults living in the community and in residential aged care. Behavioural Activation is demonstrably effective even when delivered by non-specialists (staff without formal psychological training), although strategies for adapting its use in residential aged care facilities are yet to be explored. This study will determine whether training residential care staff in the use of a structured Behavioural Activation programme is more effective at decreasing depressive symptoms among older residents than internet-based training about depression recognition and management alone. The behavioural activation in nursing homes to treat depression (BAN-Dep) trial is a pragmatic two-arm parallel clustered randomised controlled trial. It will recruit 666 residents aged 60 or older from 100 residential aged care facilities, which will be randomly assigned to the Behavioural Activation or control intervention. Staff in both treatment groups will be encouraged to complete the The trial will comply with the principles of the Declaration of Helsinki for Human Rights and is overseen by the University of Western Australia (reference RA/4/20/4234) and Melbourne Health (reference number HREC/18/MH/47) Ethics Committees. The results of this research project will be disseminated through publications and/or presentations in a variety of media to health professionals, academics, clinicians and the public. Only de-identified group data will be presented. ACTRN12618000634279.
Identifiants
pubmed: 31676658
pii: bmjopen-2019-032421
doi: 10.1136/bmjopen-2019-032421
pmc: PMC6830697
doi:
Banques de données
ANZCTR
['ACTRN12618000634279']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e032421Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Am Psychol. 1973 Oct;28(10):857-70
pubmed: 4753644
J Affect Disord. 2012 May;138(3):417-24
pubmed: 22284014
Drugs Aging. 2017 Feb;34(2):89-95
pubmed: 28074409
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
Int Psychogeriatr. 2010 Sep;22(6):927-37
pubmed: 20226111
Sci Rep. 2018 Feb 12;8(1):2861
pubmed: 29434331
Int Psychogeriatr. 2011 Mar;23(2):280-91
pubmed: 20880427
Clin Psychol Rev. 2010 Aug;30(6):608-20
pubmed: 20677369
BMC Fam Pract. 2010 Sep 01;11:63
pubmed: 20807445
Clin Psychol Rev. 2007 Apr;27(3):318-26
pubmed: 17184887
J Am Med Dir Assoc. 2010 Jun;11(5):320-4
pubmed: 20511098
J Am Med Dir Assoc. 2012 May;13(4):326-31
pubmed: 22019084
Eur J Clin Pharmacol. 2015 Dec;71(12):1429-40
pubmed: 26407688
Lancet. 2013 Jun 29;381(9885):2255-64
pubmed: 23643110
Int Psychogeriatr. 2010 Nov;22(7):1025-39
pubmed: 20522279
J Affect Disord. 2004 Jul;81(1):61-6
pubmed: 15183601
Int J Geriatr Psychiatry. 2017 Jan;32(1):32-49
pubmed: 27593707
Br J Psychiatry. 2017 Nov;211(5):274-279
pubmed: 28982660
Ageing Res Rev. 2017 Jul;36:78-87
pubmed: 28366616
BMJ. 2011 Sep 28;343:d5219
pubmed: 21957206
Aust N Z J Psychiatry. 2019 Feb;53(2):136-147
pubmed: 29488403
Lancet. 2011 Jul 30;378(9789):403-11
pubmed: 21764118
Aust N Z J Public Health. 2002 Aug;26(4):343-5
pubmed: 12233955
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
J Consult Clin Psychol. 2006 Aug;74(4):658-70
pubmed: 16881773
JAMA. 2017 Feb 21;317(7):728-737
pubmed: 28241357
Int J Geriatr Psychiatry. 2013 Mar;28(3):221-6
pubmed: 22555988
Indian J Psychiatry. 2018 Feb;60(Suppl 3):S341-S362
pubmed: 29535469
PLoS One. 2014 Jun 17;9(6):e100100
pubmed: 24936656
PLoS One. 2011;6(11):e28155
pubmed: 22140531
Int Psychogeriatr. 2011 Mar;23(2):221-9
pubmed: 20950507
Br J Gen Pract. 2019 Mar;69(680):e171-e181
pubmed: 30745355
Cochrane Database Syst Rev. 2013 Oct 16;(10):CD008696
pubmed: 24129886
J Affect Disord. 2009 May;115(1-2):54-61
pubmed: 18817976
J Gen Intern Med. 1997 Jul;12(7):439-45
pubmed: 9229283
Cochrane Database Syst Rev. 2018 Aug 31;8:CD003944
pubmed: 30168578
JAMA. 2017 May 23;317(20):2114-2122
pubmed: 28535241
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Eur J Clin Pharmacol. 2016 Aug;72(8):995-1001
pubmed: 27075194
Lancet. 2016 Aug 27;388(10047):871-80
pubmed: 27461440
J Gerontol B Psychol Sci Soc Sci. 2015 Jan;70(1):13-23
pubmed: 24691156
J Am Med Dir Assoc. 2015 Apr;16(4):296-300
pubmed: 25499429
BMC Geriatr. 2014 May 10;14:62
pubmed: 24886344
Scand J Prim Health Care. 2013 Mar;31(1):20-5
pubmed: 23330583
Int Psychogeriatr. 2005 Sep;17(3):475-85
pubmed: 16252379